GnRH agonist
A gonadotrophin-releasing hormone (GnRH) agonist that, with continuous use, suppresses sex-hormone production.
Strong clinical evidence for its approved oncology and endocrine indications.
Prescriber-managed; effects relate to sex-hormone suppression (e.g. hot flushes, bone-density considerations).
A registered prescription medicine for indications such as prostate cancer, endometriosis and precocious puberty.
Prescription-only, used within its approved indications.
This entry is general information about Leuprorelin, not a recommendation to use it. We don’t provide dosing, protocols or sourcing. Speak to a registered practitioner.
This is general education, not medical advice. Peptides.au does not sell, supply, recommend or promote any product or clinic. Always speak with a registered Australian health practitioner before making any health decision.